Cosmo Pharmaceuticals NV banner

Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 72.5 CHF -3.59%
Market Cap: CHf1.3B

Wall St Price Targets

COPN Price Targets Summary
Cosmo Pharmaceuticals NV

Wall Street analysts forecast COPN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COPN is 132.8 CHF with a low forecast of 102.01 CHF and a high forecast of 168 CHF.

Lowest Forecast
Price Target
102.01 CHF
41% Upside
Average Forecast
Price Target
132.8 CHF
83% Upside
Highest Forecast
Price Target
168 CHF
132% Upside
Cosmo Pharmaceuticals NV Competitors:
Price Targets
PALI
Palisade Bio Inc
448% Upside
JEF
Jefferies Financial Group Inc
3% Upside
FCBC
First Community Bankshares Inc
-5% Downside

Revenue
Forecast

8% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 37%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is COPN's stock price target?
Price Target
132.8 CHF

According to Wall Street analysts, the average 1-year price target for COPN is 132.8 CHF with a low forecast of 102.01 CHF and a high forecast of 168 CHF.

What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
37%

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 37%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett